| __timestamp | ADMA Biologics, Inc. | Catalyst Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 4473654 |
| Thursday, January 1, 2015 | 6745968 | 8597010 |
| Friday, January 1, 2016 | 8494742 | 7910260 |
| Sunday, January 1, 2017 | 18092835 | 7304399 |
| Monday, January 1, 2018 | 22502922 | 15875961 |
| Tuesday, January 1, 2019 | 25910757 | 36881187 |
| Wednesday, January 1, 2020 | 35050817 | 44233754 |
| Friday, January 1, 2021 | 42896889 | 49628000 |
| Saturday, January 1, 2022 | 52458024 | 58183000 |
| Sunday, January 1, 2023 | 59020000 | 133710000 |
Data in motion
In the dynamic world of biotechnology, understanding financial trends is crucial. Over the past decade, ADMA Biologics, Inc. and Catalyst Pharmaceuticals, Inc. have shown distinct patterns in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, ADMA Biologics saw a steady increase in SG&A spending, growing by over 1,100%. In contrast, Catalyst Pharmaceuticals experienced a more dramatic rise, with expenses surging by nearly 2,900% during the same period.
This divergence highlights the strategic differences between the two companies. While ADMA Biologics has maintained a consistent growth trajectory, Catalyst Pharmaceuticals' spending spiked significantly in 2023, indicating a potential shift in business strategy or market expansion. These insights provide a window into the operational priorities and financial health of these biotech firms, offering valuable lessons for investors and industry analysts alike.
Summit Therapeutics Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Sarepta Therapeutics, Inc. vs Catalyst Pharmaceuticals, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Cytokinetics, Incorporated and ADMA Biologics, Inc.
Breaking Down SG&A Expenses: TG Therapeutics, Inc. vs ADMA Biologics, Inc.
Alpine Immune Sciences, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for ADMA Biologics, Inc. and Rhythm Pharmaceuticals, Inc.
ADMA Biologics, Inc. and Xenon Pharmaceuticals Inc.: SG&A Spending Patterns Compared
ADMA Biologics, Inc. vs Ligand Pharmaceuticals Incorporated: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing ADMA Biologics, Inc. and BioCryst Pharmaceuticals, Inc.
Xenon Pharmaceuticals Inc. and Catalyst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Galapagos NV Trends and Insights
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Xencor, Inc. Trends and Insights